Becker's Healthcare January 15, 2026
Colonoscopy remains a cornerstone of colorectal cancer prevention, but GI leaders say the procedure’s role, and the business model built around it, is shifting fast.
Here’s what five leaders have told Becker’s about colonoscopy in 2025:
Omar Khokhar, MD. Gastroenterologist at Illinois GastroHealth (Bloomington): Colonoscopy demand in 2025 was a double-edged sword. On one hand, volume stayed high—screening normalization post-pandemic plus aging demographics kept our calendars full. On the other hand, that demand exposed our early choke points. We’ve come to view colonoscopy volume not as a burden but as a demand signal—one that pushes us to modernize, automate, and scale.
Lawrence Kim, MD. President of the American Gastroenterological Association Institute: We are really entering a period of transformation...
Today's Sponsors
Today's Sponsor